Dr. Reddy's Laboratories Limited: CSR spending FY 2021-22 to 2025-26
Dr. Reddy's Laboratories Limited spent ₹306.45 crore on CSR from FY 2021-22 to 2025-26 (standalone company, from its annual reports), shown year by year with the money set aside for ongoing projects.
Five-year summary
From FY 2021-22 to 2025-26 Dr. Reddy's Laboratories Limited spent ₹306.45 crore on CSR; the most was in FY 2025-26 (₹99.1 crore).
| Year | Period | Obligation (2% rule) | Spent in the year | Set aside for ongoing projects (Unspent CSR Account) | Transferred to a Schedule VII fund | Environment spend |
|---|---|---|---|---|---|---|
| FY 2025-26 | Apr 2025 - Mar 2026 | ₹111.32 crore | ₹99.1 crore | ₹12.32 crore | ₹0 crore | not disclosed |
| FY 2024-25 | Apr 2024 - Mar 2025 | ₹77.4 crore | ₹72.44 crore | ₹5.01 crore | ₹0 crore | not disclosed |
| FY 2023-24 | Apr 2023 - Mar 2024 | ₹57.35 crore | ₹57.37 crore | ₹0 crore | ₹0 crore | not disclosed |
| FY 2022-23 | Apr 2022 - Mar 2023 | ₹50.87 crore | ₹42.01 crore | ₹9.02 crore | ₹0 crore | ₹6.55 crore |
| FY 2021-22 | Apr 2021 - Mar 2022 | ₹44.77 crore | ₹35.53 crore | ₹9.28 crore | ₹0 crore | ₹2.93 crore |
| Five-year total | FY 2021-22 to 2025-26 | ₹306.45 crore |
Five-year total spent, FY 2021-22 to 2025-26: ₹306.45 crore.
Sources: Integrated Annual Report 2025-26 (BSE copy) and CSR Annual Action Plan FY26 – Dr. Reddy's Laboratories Limited; Integrated Annual Report 2024-25 (BSE copy) – Dr. Reddy's Laboratories Limited; Integrated Annual Report 2023-24 (NSE filing) – Dr. Reddy's Laboratories Limited; Integrated Annual Report 2022-23 (BSE copy) – Dr. Reddy's Laboratories Limited; Annual Report 2021-22 (BSE copy) – Dr. Reddy's Laboratories Limited
Plan your company's CSR tree planting with GreenEye
GreenEye Foundation (GEYE INNOVATION FOUNDATION) is a Section 8 non-profit registered for CSR (CSR-1 registration CSR00881842), with 12AB and 80G registration. Companies can fund tree planting with GreenEye and get geotagged photos, a tracking link and a certificate for every tree.
Talk to usShare this article